Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

He credited the medicine with keeping the atrial flutter in check. “If there’s any flare-up, then I’ll get the ablation,” ...

and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib.

Adagio Medical Holdings, Inc. , a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that its CEO & President, Olav Bergheim, will present at the ...

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has ... isthmus-dependent atrial flutter. "The Affera system was designed to address ...

and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib.

The PulseSelect™ Pulsed Field Ablation System ... Affera is a game changer for treatment of Afib and atrial flutter," said Vivek Reddy, M.D., Director of Cardiac Arrhythmia Services for the ...

Imricor’s work over past 18 years developing the world’s only MRI-compatible devices for cardiac ablation procedures is ...

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.